scholarly journals Pediocin A improves growth performance of broilers challenged with Clostridium perfringens

2009 ◽  
Vol 88 (10) ◽  
pp. 2152-2158 ◽  
Author(s):  
E. Grilli ◽  
M.R. Messina ◽  
E. Catelli ◽  
M. Morlacchini ◽  
A. Piva
Keyword(s):  
Growth Performance ◽  
Clostridium Perfringens

scholarly journals Supplementing Garlic Nanohydrogel Optimized Growth, Gastrointestinal Integrity and Economics and Ameliorated Necrotic Enteritis in Broiler Chickens Using a Clostridium perfringens Challenge Model

Animals ◽  
2021 ◽  
Vol 11 (7) ◽  
pp. 2027
Author(s):  
Doaa Ibrahim ◽  
Tamer Ahmed Ismail ◽  
Eman Khalifa ◽  
Shaimaa A. Abd El-Kader ◽  
Dalia Ibrahim Mohamed ◽  
...  
Keyword(s):  
Growth Performance ◽  
Clostridium Perfringens ◽  
Broiler Chickens ◽  
Body Weight Gain ◽  
Economic Benefits ◽  
Production Costs ◽  
Broiler Chicks ◽  
Necrotic Enteritis ◽  
Feed Conversion ◽  
Intestinal Lesion

Necrotic enteritis (NE) caused by Clostridium perfringens (C. perfringens) results in impaired bird growth performance and increased production costs. Nanotechnology application in the poultry industry to control NE outbreaks is still not completely clarified. Therefore, the efficacy of dietary garlic nano-hydrogel (G-NHG) on broilers growth performance, intestinal integrity, economic returns and its potency to alleviate C. perfringens levels using NE challenge model were addressed. A total of 1200 male broiler chicks (Ross 308) were assigned into six groups; four supplemented with 100, 200, 300 or 400 mg of G-NHG/kg diet and co-challenged with C. perfringens at 21, 22 and 23 d of age and two control groups fed basal diet with or without C. perfringens challenge. Over the total growing period, the 400 mg/kg G-NHG group had the most improved body weight gain and feed conversion efficiency regardless of challenge. Parallel with these results, the mRNA expression of genes encoding digestive enzymes (alpha 2A amylase (AMY2A), pancreatic lipase (PNLIP) and cholecystokinin (CCK)) and intestinal barriers (junctional adhesion molecule-2 (JAM-2), occludin and mucin-2 (Muc-2)) were increased in groups fed G-NHG at higher levels to be nearly similar to those in the unchallenged group. At 14 d post challenge, real-time PCR results revealed that inclusion of G-NHG led to a dose-dependently decrease in the C. perfringens population, thereby decreasing the birds’ intestinal lesion score and mortality rates. Using 400 mg/kg of G-NHG remarkably ameliorated the adverse effects of NE caused by C. perfringens challenge, which contributed to better growth performance of challenged birds with rational economic benefits.

scholarly journals A novel Bacillus based multi-strain probiotic improves growth performance and intestinal properties of Clostridium perfringens challenged broilers

2020 ◽  
Vol 99 (1) ◽  
pp. 331-341 ◽  
Author(s):  
Uraisha Ramlucken ◽  
Santosh O. Ramchuran ◽  
Ghaneshree Moonsamy ◽  
Rajesh Lalloo ◽  
Mapitsi S. Thantsha ◽  
...  
Keyword(s):  
Growth Performance ◽  
Clostridium Perfringens

scholarly journals Supplemental Bacillus subtilis PB6 Improves Growth Performance and Gut Health in Broilers Challenged with Clostridium perfringens

2021 ◽  
Vol 2021 ◽  
pp. 1-11
Author(s):  
Yan Liu ◽  
Song Zhang ◽  
Zheng Luo ◽  
Dan Liu
Keyword(s):  
Bacillus Subtilis ◽  
Growth Performance ◽  
Clostridium Perfringens ◽  
Basal Diet ◽  
Economic Losses ◽  
Control Group ◽  
Necrotic Enteritis ◽  
Dosage Group ◽  
Microbial Composition ◽  
High Dosage Group

Clostridium perfringens (CP) is the principal pathogenic bacterium of chicken necrotic enteritis (NE), which causes substantial economic losses in poultry worldwide. Although probiotics are known to provide multiple benefits, little is known about the potential effects of Bacillus subtilis (B. subtilis) application in preventing CP-induced necrotic enteritis. In this study, 450 male Arbor Acres broilers were divided into 5 experimental treatments: A: basal diet (control group); B: basal diet and CP challenge (model group); C: CP challenge+10 mg/kg enramycin (positive control group); D: CP challenge+ 4 × 10 7   CFU / kg of feed B. subtilis PB6 (PB6 low-dosage group); and E: CP challenge+ 6 × 10 7   CFU / kg of feed B. subtilis PB6 (PB6 high-dosage group). There were 6 replicate pens per treatment with 15 broilers per pen. The present research examined the effect of Bacillus subtilis PB6 (B. subtilis PB6) on growth performance, mRNA expression of intestinal cytokines and tight junctions, and gut flora composition in broilers challenged with CP. The entire experiment was divided into two phases: the non-CP challenge phase (d0–18) and the CP challenge phase (d18–26). PB6 did not increase the growth performance during the first stage, but the PB6 high-dosage group was found to have larger body weight gain and ADFI during the CP challenge stage. Feed supplementation with PB6 reduced the lesion score of challenged chicks, with increased tight junction-related gene expression (occludin and ZO-1) and decreased TNF-α expression compared with CP-infected birds. A decrease in the abundance of Clostridium XI, Streptococcus, and Staphylococcus was observed after CP infection ( P < 0.05 ), while supplementation with PB6 restored the ileal microbial composition. In conclusion, administration of B. subtilis PB6 improved growth performance, enhanced intestinal barrier function, and mitigated intestinal inflammation/lesions, which might be due to its restoring effects on the ileal microbial composition in CP-challenged broilers.

scholarly journals Effects of cLFchimera, a recombinant antimicrobial peptide, on intestinal morphology, microbiota, and gene expression of immune cells and tight junctions in broiler chickens challenged with C. perfringens

2019 ◽  
Author(s):  
Ali Daneshmand ◽  
Hassan Kermanshahi ◽  
Mohammad Hadi Sekhavati ◽  
Ali Javadmanesh ◽  
Monireh Ahmadian ◽  
...  
Keyword(s):  
Gene Expression ◽  
Antimicrobial Peptide ◽  
Growth Performance ◽  
Tight Junctions ◽  
Clostridium Perfringens ◽  
Productive Performance ◽  
Poultry Industry ◽  
Gut Health ◽  
Junctional Proteins ◽  
Challenge Group

AbstractThe current study was conducted to investigate the effects of cLFchimera, a recombinant antimicrobial peptide (AMP), on various productive performance and gut health attributes of broilers experimentally challenged with Clostridium perfringens (Cp). Three hundred and sixty 1-day-old chickens were randomly allocated to 4 treatments of 6 replicates as follows: T1) unchallenged group fed with corn-soybean meal (CSM) without Cp challenge and additives; T2) challenge group fed with CSM and challenged with Cp without any additives; T3) peptide group challenged with NE supplemented with 20 mg cLF36/kg diet (AMP); T4) antibiotic group challenged with NE and supplemented with 45 mg antibiotic (bacitracin methylene disalicylate)/kg diet (antibiotic). Birds had free access to feed and water, sampling for villi morphology and ileal microbiota were performed on days 10 and 22, while jejunal section was sampled for gene expression of cytokines, tight junctions proteins, and mucin only on day 22. Results showed that AMP ameliorated NE-related lesion in the jejunum and ileum and reduced mortality in challenged birds compared to challenge group with Cp without any additives. Also, supplementing challenged birds with AMP improved growth performance and reconstructed villi morphology. While antibiotic non-selectively reduced the count of bacteria, AMP positively restored ileal microflora in favor of good bacteria (i.e. Bifidobacteria spp. and Lactobacillus spp.). AMP beneficially regulated the expression of cytokines, junctional proteins, and mucin in the jejunum of challenged birds with Cp. Since cLFchimera ameliorated NE lesion score, reduced mortality, improved productive performance and gut health attributes in chickens compared to challenged group and also were mostly similar with those of antibiotics and therefore, it could be concluded that this chimeric peptide can be a worthy candidate to substitute growth promoter antibiotics, while more research is required to unveil the exact mode of action of this synthetic peptide.Author summaryNecrotic enteritis (NE) is a detrimental enteric disease in the poultry industry worldwide. The etiological factor of this disease is Clostridium perfringens, which is gram-positive anaerobic bacterium. This bacterium is common inhabitant of the intestine in lower counts (105), but it becomes pathogenic in higher counts and can secrete NetB toxin, which is the main cause of inducing NE in broilers. Due to the emergence of antibiotic-resistant bacteria, new generation of antimicrobial additives such as antimicrobial peptides (AMPs) has been introduced to the poultry industry. AMPs are small molecules with 12-50 amino acids having antibacterial activity. Recently, we extracted new AMP from camel milk, expressed in E. coli, refined and lyophilized to produce purified peptides. The current study investigated the effects of this peptide on prevention of NE in broilers. Results showed that AMP ameliorated lesion scores in the intestine and reduced mortality in challenged birds. AMP improved growth performance and reconstructed villi morphology in NE-challenged broilers. While antibiotic non-selectively reduced the count of bacteria, AMP positively restored ileal microflora. AMP beneficially regulated the expression of cytokines, junctional proteins, and mucin in the jejunum of NE-challenged birds.

Sign in / Sign up

Export Citation Format

Share Document